Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Decision Making: P-value Method01:09

Decision Making: P-value Method

6.5K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
6.5K
Friedman Two-way Analysis of Variance by Ranks01:21

Friedman Two-way Analysis of Variance by Ranks

398
Friedman's Two-Way Analysis of Variance by Ranks is a nonparametric test designed to identify differences across multiple test attempts when traditional assumptions of normality and equal variances do not apply. Unlike conventional ANOVA, which requires normally distributed data with equal variances, Friedman's test is ideal for ordinal or non-normally distributed data, making it particularly useful for analyzing dependent samples, such as matched subjects over time or repeated measures...
398
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

423
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
423
One-Way ANOVA01:18

One-Way ANOVA

10.7K
One-way ANOVA analyzes more than three samples categorized by one factor. For example, it can compare the average mileage of sports bikes. Here, the data is categorized by one factor - the company. However, one-way ANOVA cannot be used to simultaneously compare the sample mean of three or more samples categorized by two factors. An example of two factors would be sports bikes from different companies driven in different terrains, such as a desert or snowy landscape. Here, two-way ANOVA is used...
10.7K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

1.0K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.0K
Multiple Comparison Tests01:13

Multiple Comparison Tests

4.3K
Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Author Reply.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Battleship Science: Game-playing AI can show us how to do science better.

Scientific American·2026
Same author

Mammographic surveillance in breast cancer patients aged 50 years or older: a synopsis of the Mammo-50 RCT.

Health technology assessment (Winchester, England)·2026
Same author

The Inequality-Adjusted Incremental Cost-Effectiveness Ratio.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

AIs can 'memorize' data they shouldn't. Can they be forced to forget?

Science (New York, N.Y.)·2026
Same author

Development of the Medical Device Economic Evaluation Methodological Quality (DEEM-Q) Assessment Checklist.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same journal

Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia.

PharmacoEconomics·2026
Same journal

Applications of Structural Expert Elicitations for Economic Evaluations: A Systematic Review Update.

PharmacoEconomics·2026
Same journal

Community Pharmacist Preferences for Providing a Dose Administration Aid Service in Australia: A Discrete Choice Experiment.

PharmacoEconomics·2026
Same journal

A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.

PharmacoEconomics·2026
Same journal

Deriving a Korean SF-6Dv2 Value Set Using a Discrete Choice Experiment with Duration.

PharmacoEconomics·2026
Same journal

Correction: Ten Recommendations for Modelling Cost Effectiveness of Screening: Perspectives of an International Stakeholder Group.

PharmacoEconomics·2026
See all related articles

Related Experiment Video

Updated: Nov 29, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.8K

Probabilistic One-Way Sensitivity Analysis with Multiple Comparators: The Conditional Net Benefit Frontier.

Christopher McCabe1,2, Giovanni Tramonti3, Andrew Sutton4

  • 1Institute of Health Economics, 10405 Jasper Avenue, Edmonton, AB, 1200T5J 3N4, Canada. cmccabe@ihe.ca.

Pharmacoeconomics
|November 23, 2020
PubMed
Summary
This summary is machine-generated.

This study extends conditional incremental net benefit analysis to economic evaluations with three or more strategies. The new conditional net benefit frontier helps identify the most cost-effective options under uncertainty.

More Related Videos

A Two-interval Forced-choice Task for Multisensory Comparisons
07:13

A Two-interval Forced-choice Task for Multisensory Comparisons

Published on: November 9, 2018

11.3K
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.1K

Related Experiment Videos

Last Updated: Nov 29, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.8K
A Two-interval Forced-choice Task for Multisensory Comparisons
07:13

A Two-interval Forced-choice Task for Multisensory Comparisons

Published on: November 9, 2018

11.3K
A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.1K

Area of Science:

  • Health economics
  • Decision analysis
  • Statistical modeling

Background:

  • Uncertainty analysis in health economic evaluations is crucial but one-way sensitivity analysis methods have lagged.
  • Probabilistic one-way sensitivity analysis (OWSA) is key for understanding parameter uncertainty.
  • Conditional incremental net benefit (CINB) was recently introduced for two-strategy comparisons.

Purpose of the Study:

  • To generalize the conditional net benefit approach for economic evaluations comparing three or more strategies.
  • To introduce the conditional net benefit frontier for identifying optimal strategies under parameter uncertainty.

Main Methods:

  • Generalization of the conditional incremental net benefit (CINB) concept.
  • Development and application of the conditional net benefit frontier.
  • Probabilistic one-way sensitivity analysis for multi-strategy comparisons.

Main Results:

  • Conditional net benefit can be effectively used for probabilistic OWSA in multi-strategy economic evaluations.
  • The conditional net benefit frontier enables identification of the most cost-effective strategy given specific parameter values.

Conclusions:

  • The generalized conditional net benefit framework enhances uncertainty analysis in health economic evaluations.
  • The conditional net benefit frontier provides a valuable tool for decision-making in complex health care program comparisons.